Aims & Scope
The Journal of Alzheimer’s Disease is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment and psychology of Alzheimer’s disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. The journal is dedicated to providing an open forum for original research that will expedite our fundamental understanding of Alzheimer’s disease.
In Remembrance of Editor-in-Chief Mark A. Smith
In 2018, JAD celebrated its 20th anniversary (see details here).
In association with JAD, a number of book titles relating to Alzheimer's disease are published by IOS Press. These include the book that was published to commemorate the centennial in 2006 of Alois Alzheimer's discovery of what would become to be known as Alzheimer's disease, as well as the book series Advances in Alzheimer's Disease (AIAD), which has an always increasing number of titles. The forward-looking book in the AIAD series was published in July 2018 (to order click here) and the gut microbiome title in July 2022 (to order click here).
Editorial Board
Editor-in-Chief
George Perry, PhD
University of Texas at San Antonio
One UTSA Circle
San Antonio, Texas 78249
USA
Tel: +1 210 458 4450
Fax:+1 210 458 4445
Email: george.perry@utsa.edu
ORCID: 0000-0002-6547-0172
Managing Editor
Beth Kumar
Department of Pathology
Case Western Reserve University
2103 Cornell Road
Cleveland, Ohio 44106
USA
Tel:+1 216 368 3671
Fax:+1 216 368 8964
Email: editorial@j-alz.com
ORCID: 0000-0002-6547-0172
Former Editor-in-Chief (2001–2010)
Regional Editors
Sergio Ferreira
Jianping Jia
Amos Korczyn
Ricardo Maccioni
Pravat Mandal
Colin Masters
Akihiko Nunomura
Xinglong Wang
Jing Zhang
Deputy Editors
Jesus Avila
Paula Moreira
Massimo Tabaton
Xiongwei Zhu
Reviews Editor
Ethics Editor
Prevention Editor
Scientometrics Editor
Senior Editors
Benedict Albensi
Kaarin Anstey
Mark Bondi
Lilian Calderón-Garcidueñas
Jack de la Torre
M. Arfan Ikram
Jianping Jia
Yong Liu
David Loewenstein
Riccardo Maccioni
Ralph Martins
Jordi Matías-Guiu
Giulio Pasinetti
Cyrus Raji
Jagannatha Rao Kosagisharaf
Lan Tan
Jin-Tai Yu
Ling-Qiang Zhu
Associate Editors
Full list of the Associate Editors at: j-alz.com/board.
Editorial Board
Full list of the Editorial Board at: j-alz.com/board.
Author Guidelines
SUBMISSION OF MANUSCRIPT
By submitting my article to this journal, I agree to the Author Copyright Agreement, the IOS Press Ethics Policy, and the IOS Press Privacy Policy.
See the full instructions to authors on the JAD website.
COPYRIGHT
Copyright of your article
Authors submitting a manuscript do so on the understanding that they have read and agreed to the terms of the IOS Press Author Copyright Agreement.
Article sharing
Authors of journal articles are permitted to self-archive and share their work through institutional repositories, personal websites, and preprint servers. Authors have the right to use excerpts of their article in other works written by the authors themselves, provided that the original work is properly cited. The consent for sharing an article, in whole or in part, depends on the version of the article that is shared, where it is shared, and the copyright license under which the article is published. Please refer to the IOS Press Article Sharing Policy for further information.
Quoting from other publications
Authors, when quoting from someone else's work or when considering reproducing figures or tables from a book or journal article, should make sure that they are not infringing a copyright. Although in general authors may quote from other published works, permission should be obtained from the holder of the copyright if there will be substantial extracts or reproduction of tables, plates, or other figures. If the copyright holder is not the author of the quoted or reproduced material, it is recommended that the permission of the author should also be sought. Material in unpublished letters and manuscripts is also protected and must not be published unless permission has been obtained. Submission of a paper will be interpreted as a statement that the author has obtained all the necessary permission. A suitable acknowledgement of any borrowed material must always be made.
Please visit the IOS Press Authors page for further information.
Abstracted/Indexed in
CAB Abstracts
Cabell's Guide or Directory
Chemical Abstracts Service (CAS)
CSA Biological Sciences
CSA Illumina
CSA Illustrata Natural Sciences
CSA Neurosciences Abstracts
e-psyche database
EBSCO Databases
Embase
EMCare
EVISA - European Virtual Institute for Speciation Analysis
Index Medicus
MEDLINE
OA @ PubMedCentral
Prous Science Integrity
PsycINFO
PubMed
PubsHub
SciVerse Scopus
Ulrich's Periodicals Directory
Web of Science: Biological Abstracts
Web of Science: BIOSIS Previews
Web of Science: Journal Citation Reports/Science Edition
Web of Science: Science Citation Index Expanded (SciSearch®)
Open Access
By default, articles published in the Journal of Alzheimer’s Disease are available only to institutions and individuals with access rights. However, the journal offers all authors the option to purchase open access publication for their article as part of the IOS Press Open Library. This means that the final published version will be freely available to anyone worldwide, indefinitely, under a Creative Commons license and without the need to purchase access to the article. This is also referred to as “gold” open access.
Gold open access pricing
Authors who choose gold open access publication will be subject to an article publication charge of €1800 / US$1800 for publication under the CC BY-NC 4.0 license or €2150 / US$2150 for publication under the CC BY 4.0 license. Pricing is exclusive of possible taxes. After an article is accepted for publication, the corresponding author will be informed regarding the open access option during the production stages, and will have the opportunity to purchase open access for their article. It could be that the open access fee of an article is waived completely due an institutional agreement IOS Press has with the corresponding authors' institution. Please check the institutional agreements page for details.
Green open access
Authors who do not make use of the gold open access option may still make their article freely available using self-archiving, also referred to as green open access. Authors may make their final accepted manuscript available for free download from their personal or institutional website or institutional archive. This model is free for the author.
PubMedCentral deposits
This journal deposits all open access articles in PubMedCentral (PMC) as part of the IOS Press Open Library. If an author chooses to publish their paper with open access then the publisher will deposit the article in PMC upon publication.
Social Media & Mailings – The Journal of Alzheimer's Disease (JAD) is on Facebook and Twitter, so be sure to follow us and be part of the conversation! JAD also issues regular newsletters; not signed up yet? You can do so here: tiny.cc/JADsignup. Read the recent newsletter here.
Discover our fully open access Alzheimer's journal – Perhaps you are also interested in JAD's sister journal, the open access Journal of Alzheimer's Disease Reports? See the contents here, and click here to view the newsletter of JADR Volume 6 for content published in Q1 2022.
JAD 20th Anniversary – During 2018, JAD had its 20th anniversary and to mark this occasion an open access issue of the journal was published in Vol.62, Iss.3 (view here). To read our special commorative publication, click here (PDF). Read our anniversary year summary here!
Latest Articles
Discover the contents of the latest journal issue:
Retinal Examinations Provides Early Warning of Alzheimer’s Disease
Qi Qin, Xinyi Xia, Yankun Peng, Meng Wang, Yunsi Yin, Yi Tang
Touchscreen Cognitive Tools for Mild Cognitive Impairment and Dementia Used in Primary Care Across Diverse Cultural and Literacy Populations: A Systematic Review
Petronilla Battista, Francesco Giaquinto, Paola Angelelli
Synaptic Proteins as Fluid Biomarkers in Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Aurora Cermelli, Fausto Roveta, Silvia Boschi, Fabio Ferrandes, Alberto Grassini, Andrea Marcinnò, Margherita Spina, Elisa Rubino, Tiziana Borsello, Alessandro Vercelli, Innocenzo Rainero
Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy Trials
Mona-Elisabeth Revheim, Poul F. Høilund-Carlsen, Abass Alavi, Nagichettiar Satyamurthy, Jorge R. Barrio
It’s Groundhog Day! What Can the History of Science Say About the Crisis in Alzheimer’s Disease Research?
Bert Theunissen, Noortje Jacobs
Sustainable Development Goals
The content of this journal relates to SDG:
Visit the SDG page for more information.
Supporting Diversity and Inclusion
This journal supports IOS Press' actions relating to the Sustainable Development Goals (SDGs) and commits to the Diversity and Inclusion Statement.
More information will be available in due course. Check the SDGs page for updates.
